Two of the World Health Organization’s (WHO) cannabis scheduling recommendations might face an uphill battle getting adopted later this year by the United Nations’ Commission on Narcotic Drugs (CND). That revelation stems from an analysis of statements made by U.N.-member states at a recent two-day CND meeting. Still, many in the cannabis industry are hoping for a positive outcome at the end of the year, when a vote is planned. The reason: If the two recommendations discussed at the CND meeting in June are approved, international trade in certain CBD preparations is expected to become more free.